Impact of neuroleptic medications on continuous performance test measures in schizophrenia

Biological Psychiatry

Volumn 39, Issue 10, 1996, Pages 902-905

  Epstein, Jane I ^a   Keefe, Richard S E ^a   Roitman, Sonia Lees ^a   Harvey, Philip D ^a   Mohs, Richard C ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Attention; Continuous performance test; Medication; Neuroleptic; Schizophrenia

Indexed keywords

BENZATROPINE; HALOPERIDOL; NEUROLEPTIC AGENT; THIORIDAZINE; TIOTIXENE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; TASK PERFORMANCE;

EID: 0030015267     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00588-9     Document Type: Article

References (15)

1. Cohen J (1988): Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates.
2. Cornblatt B, Erlenmeyer-Kimling L (1985): Global attentional deviance as a marker of risk for schizophrenia: Specificity and predictive validity. J Abnorm Psychology 94:470-486.
3. Cornblatt B, Lenzenweger M, Erlenmeyer-Kimling L (1989): The continuous performance test, idential pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients. Psychiatry Res 29:6585.
4. Davidson M, Kahn R, Knott P, et al (1991a): Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Arch Gen Psychiatry 48:910-913.
5. Davidson M, Kahn R, Powchik P, et al (1991b): Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation. Arch Gen Psychiatry 48:73-76.
6. Grier J (1971): Non-parametric indices for sensitivity and bias. Psychol Bull 75:424-429.
7. Harvey P, Keefe R, Moskowitz J, et al (1990): Attentional markers of vulnerability to schizophrenia: Performance of medicated and unmedicated patients and normals. Psychiatry Res 33:179-188.
8. Medalia A, Gold J, Merriam A (1988): The effects of neuroleptics on neuropsychological test results in schizophrenics. Arch Clin Neuropsychol 3:249-271.
9. Nuechterlein K, Dawson M (1984): Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 10:160-203.
10. Nuechterlein K, Edell W, Norris M, Dawson M (1986): Attentional vulnerability indicators, thought disorder, and negative symptoms. Schizophr Bull 12:408-426.
11. Obiols J, Garcia-Domingo M, deTrincheria I, Domenech E (1993): Psychometric schizotypy and sustained attention in young males. Personality Individual Diff 14:381-384.
12. Overall K, Gorham D (1968): The brief psychiatric rating scale. Psychol Rep 10:799-812.
13. Serper M, Bergman R, Harvey P (1990): Medication may be required for the development of automatic information processing in schizophrenia. Psychiatry Res 32:281-288.
14. Spitzer R, Endicott J, Robins L (1978): The Schedule for Affective Disorders and Schizophrenia. New York: Biometrics Research.
15. Wohlberg G, Kornetsky C (1973): Sustained attention in remitted schizophrenics. Arch Gen Psychiatry 28:533-537.